None
Quote | Northwest Biotherapeutics Inc. (OTCMKTS:NWBO)
Last: | $1.04 |
---|---|
Change Percent: | 1.0% |
Open: | $0.99 |
Close: | $1.04 |
High: | $1.09 |
Low: | $0.9501 |
Volume: | 3,837,568 |
Last Trade Date Time: | 09/25/2023 03:00:00 am |
News | Northwest Biotherapeutics Inc. (OTCMKTS:NWBO)
LAS VEGAS, NV / ACCESSWIRE / September 25, 2023 / Crown Equity Holdings, Inc. (OTC PINK:CRWE) today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a proposed public offering of its common stock. The public offering is ...
Northwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's Scientific Advisory Board PR Newswire BETHESDA, Md. , Sept. 12, 2023 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax ...
Message Board Posts | Northwest Biotherapeutics Inc. (OTCMKTS:NWBO)
Subject | By | Source | When |
---|---|---|---|
https://brownneurosurgery.com/breakthrough-brain-cancer-vaccine/ | hope4patients | investorshub | 09/25/2023 10:56:42 PM |
Absolutely | hope4patients | investorshub | 09/25/2023 10:55:56 PM |
Same. | StonkMaster | investorshub | 09/25/2023 10:48:16 PM |
Everyone of the shorts on here know site | extrooper | investorshub | 09/25/2023 10:46:56 PM |
The SEC keeps that FTD data updated every | sentiment_stocks | investorshub | 09/25/2023 10:45:46 PM |
Northwest Biotherapeutics Inc. Company Name:
NWBO Stock Symbol:
OTCMKTS Market:
Northwest Biotherapeutics Inc. Website:
LAS VEGAS, NV / ACCESSWIRE / September 25, 2023 / Crown Equity Holdings, Inc. (OTC PINK:CRWE) today announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (the "SEC") for a proposed public offering of its common stock. The public offering is ...
Northwest Biotherapeutics Announces That Dr. Linda Liau Has Joined The Company's Scientific Advisory Board PR Newswire BETHESDA, Md. , Sept. 12, 2023 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company developing DCVax ...
Northwest Biotherapeutics Announces Completion of Prerequisites, and Plans for Submission of Marketing Authorization Application PR Newswire BETHESDA, Md. , Aug. 29, 2023 /PRNewswire/ -- Northwest Biotherapeutics (OTCQB: NWBO) ("NW Bio"), a biotechnology company ...